Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glutamine in Functional Dyspepsia
NCT05655819Phase 2Completed
- Start
- Feb 2023
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of glutamine in functional dyspepsia (FD). Started Feb 2023; status: completed.
02
Drugs
glutamine
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT05655819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05655819.